targeted doxorubicin therapy for ovarian cancer (Genisphere)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nametargeted doxorubicin therapy for ovarian cancer (Genisphere)
Drug Alias NamedoxorubicinGL-241
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus DNA polymerase inhibitorsTopoisomerase II inhibitors
TargetsVirus DNA polymeraseTopoisomerase II
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenisphere
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenisphere
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A